Journal article
Thiazolidinediones and Their Effect on Bone Metabolism: A Review
Abstract
Thiazolidinediones (TZDs) are a class of antihyperglycemic agents commonly used in the treatment of type 2 diabetes mellitus. It is accepted that through activation of peroxisome proliferator-activated receptor (PPAR) gamma, TZDs have an effect on bone metabolism. People with diabetes are already at an increased risk of fractures due to multiple factors, but recent incidental findings in A Diabetes Outcome Progression Trial (ADOPT) have …
Authors
Lau A; Harper W
Journal
Canadian Journal of Diabetes, Vol. 31, No. 4, pp. 378–383
Publisher
Elsevier
Publication Date
2007
DOI
10.1016/s1499-2671(07)14010-7
ISSN
1499-2671